Document Actions

You are here: Home › … › Research Funding › Funded Projects and … › Funded Collaborative Research …

Funded Collaborative Research Projects

Collaborative Research Centers (CRC) und Collaborative Research Center/Transregio (CRC/TRR) with a spokesperson from the Faculty of Medicine

  • SFB 992: Medical Epigenetics - From basic mechanisms to clinical applications (MEDEP)
    • Spokesperson: Prof. Dr. Roland Schüle
    • Funding period: 07/2012 – 06/2024 (3rd Funding period)
  • SFB 1160: Immune-mediated pathology as a consequence of impaired immune reactions (IMPATH)
    • Spokesperson: Prof. Dr. Stephan Ehl
    • Funding period: 07/2015 – 06/2027 (3rd Funding period)
  • SFB 1381: Dynamic Organization of Cellular Protein Machineries: From Biogenesis and Modular Assembly to Function
    • Spokesperson: Prof. Dr. Chris Meisinger
    • Funding period: 07/2019 – 06/2027 (2nd Funding period)
  • SFB 1425: Heterocellular Nature of Cardiac Lesions: Identities, Interactions, Implications (ScarCare)
    • Spokesperson: Prof. Dr. Peter Kohl
    • Funding period: 07/2020 – 06/2024 (1st Funding period)
  • SFB 1453: Nephrogenetics (NephGen)
    • Spokesperson: Prof. Dr. Anna Köttgen
    • Funding period: 01/2021 – 12/2024 (1st Funding period)
  • SFB 1479: Oncogene-driven immune escape (OncoEscape)
    • Spokesperson: Prof. Dr. Robert Zeiser
    • Funding period: 07/2021 – 06/2025 (1st Funding period)
  • SFB 1597: Small Data
    • Spokesperson: Prof. Dr. Harald Binder
    • Funding period: 10/2023 – 06/2027 (1st Funding period)
  • SFB/TRR 167: Development, function and potential of myeloid cells in the central nervous system (NeuroMac)
    • Spokesperson: Prof. Dr. Marco Prinz
    • Funding period: 01/2017 – 12/2024 (2nd Funding period)
  • SFB/TRR 359: Perinatal Development of Immune Cell Topology (PILOT)
    • Spokesperson: Prof. Dr. Philipp Henneke
    • Funding period: 01/2023 – 12/2026 (1st Funding period)
  • SFB/TRR 384: Inhibitory neurons: shaping the cortical code (IN-CODE)
    • Spokesperson: Prof. Dr. Marlene Bartos
    • Funding period: 04/2024 - 12/2027 (1st Funding period)

 

Collaborative Research Centers (CRC) und Collaborative Research Center/Transregio (CRC/TRR) with participation of the Faculty of Medicine

  • SFB 1177: Molecular and Functional Characterization of Selective Autophagy
    • Spokesperson: Prof. MD PhD Ivan Dikic (Goethe University Frankfurt)
    • Funding period: 01/2016 – 12/2027 (3rd Funding period)
  • SFB/TRR 152: TRiPs to Homeostasis. Maintenance of Body Homeostasis by Transient Receptor Potential Channel Modules
    • Spokesperson: Prof. Dr. Thomas Gudermann (LMU Munich)
    • Funding period: 07/2014 - 06/2026 (3rd Funding period)
  • SFB/TRR 179: Determinants and dynamics of elimination versus persistence of hepatitis virus infection
    • Spokesperson: Professor Dr. Ralf Friedrich Wilhelm Bartenschlager (German Cancer Research Center and Heidelberg University)
    • Funding period: 07/2016 – 06/2024 (2nd Funding period)
    • Spokesperson: Professor Dr. Thomas Brunner (Konstanz University)
    • Funding period: 10/2023 – 06/2027 (1st Funding period)

 

DFG-Research Units (FOR) with a spokesperson from the Faculty of Medicine

  • FOR 2674: Aging-related epigenetic remodeling in acute myeloid leukemia
    • Spokesperson: Prof. Dr. Michael Lübbert
    • Funding period: 2017 – 2025 (2nd Funding period)
  • FOR 5476: Urothelial Carcinoma Epigenetics
    • Spokesperson: Prof. Dr. Ian Frew
    • Funding period: 2024 – 2028 (1st Funding period)

 

DFG-Research Units (FOR) with participation of the Faculty of Medicine

  • FOR 2830: Advanced Concepts in Cellular Immune Control of Cytomegalovirus
    • Spokesperson: Prof. Dr. Lars Dölken (University of Würzburg)
    • Funding period: 2019 - 2027 (2nd Funding period)
  • FOR 5159: Resolving prefrontal flexibility
    • Spokesperson: Prof. Dr. Ileana Livia Hanganu-Opatz (ZMNH Universität Hamburg)
    • Funding period: 2021 - 2025 (1st Funding period)

 

Graduate Schools (GSC) / Integrated Research Training Groups (IRTG) / Research Training Groups (GRK) with a spokesperson from the Faculty of Medicine

  • GSC 4: Spemann Graduate School of Biology and Medicine (SGBM)
  • IRTG (integrated SFB 992): Medical Epigenetics (MEDEP)
    • Spokesperson: Prof. Dr. Roland Schüle
    • Funding period: 07/2012 – 06/2024 (3rd Funding period)
  • IRTG (integrated SFB 1479): Oncogene-driven immune escape (OncoEscape)
    • Spokesperson: Prof. Dr. Melanie Börries
    • Funding period: 07/2021 – 06/2025 (1st Funding period)
  • IRTG (integrated SFB 1597): SMART
    • Spokesperson: Dr. Nadine Binder, Prof. Dr. Rolf Backofen
    • Funding period: 10/2023 – 06/2027 (1st Funding period)
  • IRTG (integrated SFB/TRR 359): CoPILOT
    • Spokesperson: Prof. Dr. Markus Sperandio (LMU Munich), Prof. Dr. Katrin Kierdorf
    • Funding period: 01/2023 – 12/2026 (1st Funding period)
  • GRK 2344: MeInBio - BioInMe: Exploration of spatio-temporal dynamics of gene regulation using high-throughput and high-resolution methods
    • Spokesperson: Prof. Dr. Tanja Vogel
    • Funding period: 09/2017 – 08/2026 (2nd Funding period)
  • GRK 2606: Understanding protease functions in cellular pathways through discovery and analysis of protease substrates (ProPath)
    • Spokesperson: Prof. Dr. Thomas Reinheckel
    • Funding period:01/2021 – 06/2025 (1st Funding period)

 

Graduate Schools (GSC) / Integrated Research Training Groups (IRTG) / Research Training Groups (GRK) with participation of the Faculty of Medicine

  • GRK 2202: Transport across and into membranes
    • Spokesperson: Prof. Dr. Thorsten Friedrich (Faculty of Chemistry and Pharmacy, University of Freiburg)
    • Funding period: 06/2016 – 06/2025 (2nd Funding period)

 

Priority Programmes (SPP) with a spokesperson from the Faculty of Medicine

  • SPP 2177: Radiomics: Next Generation of Biomedical Imaging
    • Spokesperson: Prof. Dr. Fabian Bamberg
  • SPP 2502: EPIADAPT: Epigenomische Adaptationen des sich entwickelnden neuralen Chromatins
    • Spokesperson: Prof. Dr. Tanja Vogel

       

Priority Programmes (SPP) with participation of the Faculty of Medicine

  •  SPP 1926: Next Generation Optogenetics: Tool Development and Application
    • Spokesperson: Prof. Dr. Alexander Gottschalk (Goethe University Frankfurt)

 

 Structured young researchers programs

 

Excellence Strategy: Cluster of Excellence

 

Excellence Initiative: Cluster of Excellence

 

Joint research projects and networks

 

National Cohort (NaKo)

The Institute for Prevention and Cancer Epidemiology is one of 18 study centers throughout Germany. Between 2013 and 2017 10.000 people from all over Germany had already participated in the study in Freiburg.

 

Participations on German Health Research Centers